NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...

There's good news for those with multiple sclerosis (MS). A new study has found that female participants were no more likely to have a flare-up of the disease after receiving fertility treatments than ...

Illustration showing demylination, a process in which the myelin sheath of neurons is damaged. This damage is seen in demyelinating diseases, such as multiple sclerosis and other demyelinating ...

that affects the central nervous system. There are various types of MS. Several of these are characterized by inflammation and damage due to demyelination and scarring in the central nervous system, ...

OTTAWA — The use of oral rather than intravenous (IV) steroids to respond to relapses in patients with relapsing-remitting multiple sclerosis (RRMS) is growing, a study suggested. The data, which were ...

September 19, 2012 — Full results of two phase 3 trials evaluating the effect of oral BG-12 (dimethyl fumarate, Biogen Idec) in patients with multiple sclerosis (MS) show the investigational agent ...

"The observed differential effects of high-efficacy disease-modifying agents across sexes underscore the importance of sex-specific considerations in making treatment decisions to personalize care in ...

DENVER, CO – Mitoxantrone, a chemical routinely used to fight breast cancer, leukemia and malignant lymphoma, has found a new disease to battle: Multiple Sclerosis. Used in an initial intensive course ...

Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...

The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...

Cladribine, a nucleotide (deoxyadenosine) analogue, inhibits deoxyribonucleic acid (DNA) synthesis in proliferating lymphocytes, causing DNA damage and depleting their number by apoptosis and ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...